Cargando…
Interspecies and in vitro‐in vivo scaling for quantitative modeling of whole‐body drug pharmacokinetics in patients: Application to the anticancer drug oxaliplatin
Quantitative systems pharmacology holds the promises of integrating results from laboratory animals or in vitro human systems into the design of human pharmacokinetic/pharmacodynamic (PK/PD) models allowing for precision and personalized medicine. However, reliable and general in vitro‐to‐in vivo ex...
Autores principales: | Catozzi, Simona, Hill, Roger, Li, Xiao‐Mei, Dulong, Sandrine, Collard, Elodie, Ballesta, Annabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931436/ https://www.ncbi.nlm.nih.gov/pubmed/36537068 http://dx.doi.org/10.1002/psp4.12895 |
Ejemplares similares
-
Sex and Circadian Timing Modulate Oxaliplatin Hematological and Hematopoietic Toxicities
por: Dulong, Sandrine, et al.
Publicado: (2022) -
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
por: Brown, Sarah D., et al.
Publicado: (2010) -
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
por: Bertholee, Daphne, et al.
Publicado: (2016) -
Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy
por: Hill, Roger J. W., et al.
Publicado: (2020) -
A Combined Experimental and Mathematical Approach for Molecular-based Optimization of Irinotecan Circadian Delivery
por: Ballesta, Annabelle, et al.
Publicado: (2011)